Tap to React
Tap to React

Organisers


Nature Italy

Nature Italy is a standalone digital magazine that reports on scientific research, and issues of science policy, in Italy. Stories will be relevant to researchers and a wider audience of people interested in science.

Through a mixture of research highlights, science news and feature stories written by science journalists, readers will be able to keep up with the latest Italian research. Nature Italy also offers opinion pieces and commentaries, providing a platform for the scientific community to provide their perspectives on scientific matters.

Nature Neuroscience 
Nature Neuroscience is a multidisciplinary journal that publishes papers of the highest quality and significance in all areas of neuroscience. The editors welcome contributions in molecular, cellular, systems and cognitive neuroscience, as well as psychophysics, computational modeling and diseases of the nervous system. No area is excluded from consideration, although priority is given to studies that provide fundamental insights into the functioning of the nervous system.

Nature Neuroscience provides readers and authors high visibility, emphasis on interdisciplinary communication, accessibility to a broad readership, high standards of copy editing and production, rigorous peer review, rapid publication, and independence from academic societies and other vested interests.

Eye
Eye seeks to provide the international practising ophthalmologist with high quality articles, of academic rigour, on the latest global clinical and laboratory based research. Its core aim is to advance the science and practice of ophthalmology with the latest clinical- and scientific-based research. Whilst principally aimed at the practising clinician, the journal contains material of interest to a wider readership including optometrists, orthoptists, other health care professionals and research workers in all aspects of the field of visual science worldwide. Eye is the official journal of The Royal College of Ophthalmologists.
Dompé
Dompé is a private, rapidly scaling global biopharmaceutical company founded in Milan, Italy, with a 130-year legacy of medical innovation. Currently, the company employs over 900 individuals across Europe, the United States, and China and maintains a U.S. commercial operations hub in the San Francisco Bay Area as well as an R&D presence in Boston.

Dompé's primary focus lies in the research and development of biopharmaceutical therapeutic products. The company operates in two main business areas: Primary & Specialty Care and Biotech. The Primary & Specialty Care segment encompasses a diverse range of over-the-counter therapeutic solutions, prescription drugs, supplements, and medical devices in Italy and Europe. Biotech focuses on developing treatments for high unmet medical needs. The company manages the entire supply chain, from initial drug discovery to final manufacturing and product commercialization.